(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 6827.90 | 5263.10 | 29.73 | 6827.90 | 5263.10 | 29.73 | 22755.80 | 17162.90 | 32.59 |
| Other Income | 92.30 | 112.40 | -17.88 | 92.30 | 112.40 | -17.88 | 284.90 | 406.30 | -29.88 |
| PBIDT | 581.70 | 923.50 | -37.01 | 581.70 | 923.50 | -37.01 | 2905.20 | 2946.00 | -1.38 |
| Interest | 19.50 | 7.20 | 170.83 | 19.50 | 7.20 | 170.83 | 44.90 | 14.60 | 207.53 |
| PBDT | 559.80 | 912.70 | -38.67 | 559.80 | 912.70 | -38.67 | 2807.80 | 1963.50 | 43.00 |
| Depreciation | 52.30 | 165.70 | -68.44 | 52.30 | 165.70 | -68.44 | 285.80 | 399.90 | -28.53 |
| PBT | 507.50 | 747.00 | -32.06 | 507.50 | 747.00 | -32.06 | 2522.00 | 1563.60 | 61.29 |
| TAX | 128.20 | 188.70 | -32.06 | 128.20 | 188.70 | -32.06 | 646.80 | 406.20 | 59.23 |
| Deferred Tax | 19.50 | -32.30 | -160.37 | 19.50 | -32.30 | -160.37 | 52.60 | -199.20 | -126.41 |
| PAT | 379.30 | 558.30 | -32.06 | 379.30 | 558.30 | -32.06 | 1875.20 | 1157.40 | 62.02 |
| Equity | 50.00 | 50.00 | 0.00 | 50.00 | 50.00 | 0.00 | 50.00 | 50.00 | 0.00 |
| PBIDTM(%) | 8.52 | 17.55 | -51.45 | 8.52 | 17.55 | -51.45 | 12.77 | 17.16 | -25.62 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1934.90 |
| Dr. Reddys Labs. | 1197.10 |
| Cipla | 1463.80 |
| Lupin | 2255.70 |
| Zydus Lifesciences | 1197.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: